Save 20% with code MAY5
0

Vasoactive Intestinal Peptide (VIP) in Respiratory and Pulmonary Research Models

Vasoactive Intestinal Peptide (VIP), also known as Vasoactive Intestinal Polypeptide, is a 28–amino acid neuropeptide belonging to the secretin/glucagon peptide family. It is widely distributed in the nervous, immune, and respiratory systems, where it serves as a potent vasodilator and smooth muscle relaxant (Said).

In respiratory and pulmonary research, VIP is studied for its ability to regulate airway tone, pulmonary vascular resistance, and inflammatory responses. Its influence extends beyond the lungs, acting as a signaling molecule between neural, immune, and epithelial tissues (Wu et al.). This blog explores VIP’s mechanistic pathways, observed biological effects, and research applications in respiratory models related to airway relaxation, pulmonary hypertension, and inflammation (Groneberg et al.).

What Is Vasoactive Intestinal Peptide (VIP)?

Discovered in the early 1970s, VIP was initially identified as a peptide involved in intestinal vasodilation but was later found to be a multifunctional regulatory molecule (Said & Henning). It is synthesized and released by neurons, immune cells, and epithelial tissues and exerts its activity by binding to two G protein–coupled receptors, VPAC1 and VPAC2 (Igarashi et al.).

These receptors are expressed in various tissues, including airway smooth muscle, pulmonary vasculature, and immune cells, giving VIP a broad physiological range (Miotto et al.). Its dual classification as both a neuropeptide and immunomodulator makes it a valuable model for studying how nervous and immune signaling intersect in the regulation of respiratory function.

For a comprehensive overview of VIP’s broader physiological and cellular functions, see our overview article:

Mechanism of Action

The biological activity of VIP is mediated through its binding to VPAC1 and VPAC2 receptors, which activate adenylate cyclase, leading to increased intracellular cyclic AMP (cAMP) levels. Elevated cAMP subsequently activates protein kinase A (PKA) and other downstream effectors responsible for smooth muscle relaxation and vascular dilation (Dickson & Finlayson).

In the respiratory system, VIP’s effects are twofold. First, it relaxes bronchial and tracheal smooth muscle, reducing airway resistance and promoting bronchodilation. Second, it dilates pulmonary blood vessels, thereby decreasing pulmonary arterial pressure and improving oxygenation (St. Hilaire et al.).

Beyond these mechanical actions, VIP also plays a role in immune modulation and inflammation control. It has been shown to inhibit pro-inflammatory cytokines such as TNF-α, IL-6, and IL-8 while promoting the release of anti-inflammatory mediators like IL-10. VIP signaling can downregulate NF-κB activation, reducing inflammatory cell recruitment within lung tissue (Abad & Tan).

This combination of smooth muscle relaxation, vascular regulation, and cytokine modulation positions VIP as a model neuropeptide for studying both pulmonary function and immune homeostasis in respiratory research.

Biological Effects and Observed Benefits

The mechanisms triggered by VIP have produced several notable outcomes in experimental respiratory and vascular models.

Research indicates that VIP promotes airway relaxation, leading to improved bronchial patency and reduced airway constriction in models of asthma and reactive airway disease. Its vasodilatory effect contributes to decreased pulmonary vascular resistance, supporting studies on pulmonary hypertension and hypoxia-induced vasoconstriction (Said).

VIP has also been observed to exert anti-inflammatory and cytoprotective effects in epithelial and immune systems. It reduces inflammatory cytokine release, limits oxidative stress, and preserves epithelial barrier integrity under stress conditions (Said). These findings suggest a potential role for VIP in maintaining respiratory homeostasis and preventing tissue damage caused by inflammation or hypoxia.

Additionally, research on neuroimmune interactions highlights VIP’s ability to modulate macrophage and T-cell activity, reinforcing its importance in maintaining the balance between immune tolerance and inflammatory response within pulmonary environments (Szema et al.).

Together, these findings position VIP as a key peptide for studying airway relaxation, vascular regulation, and inflammation control in respiratory research.

Research Applications and Experimental Contexts

Building on its well-characterized mechanisms, VIP is used across several research domains investigating airway physiology, pulmonary vascular control, and inflammation.

01

Airway and Smooth Muscle Research

In pulmonary studies, VIP is applied to examine bronchodilation mechanisms and smooth muscle relaxation in models of airway hyperresponsiveness and asthma. Research uses these systems to understand how neuropeptides influence airway tone and resistance under different stimuli (Groneberg et al.).

02

Pulmonary Hypertension and Vascular Studies

VIP’s vasodilatory properties make it a valuable tool in models of pulmonary hypertension, where it helps explore mechanisms of vascular remodeling, endothelial regulation, and oxygenation dynamics. Studies have reported improved perfusion and reduced pulmonary arterial pressure following VIP exposure (Said).

03

Inflammation and Immune Regulation

Research into chronic inflammatory airway diseases, such as COPD and asthma, has shown that VIP modulates immune cell recruitment and cytokine production, providing insight into how neuropeptides regulate inflammatory responses in lung tissue (Mathioudakis et al.).

04

Neuroimmune and Epithelial Interaction Studies

Because VIP is co-localized with sensory and parasympathetic neurons, it is also used in research exploring neural–immune cross-talk and epithelial protection. These studies contribute to understanding how the nervous system coordinates airway integrity and immune defense (Said).

Together, these research applications define VIP as a multifunctional peptide model that bridges the study of airway physiology, vascular homeostasis, and immune regulation in respiratory science.

Comparison to Similar Peptides

In respiratory and vascular research, VIP is frequently compared with other peptides that influence airway tone, vascular regulation, and immune balance. While these molecules share overlapping mechanisms, VIP is distinguished by its dual action as both a bronchodilator and an anti-inflammatory regulator within pulmonary systems.

Peptide Primary Research Focus Mechanism of Interest Distinctive Feature
VIP (Vasoactive Intestinal Peptide) Airway relaxation and vascular regulation Activates VPAC1/VPAC2 receptors → cAMP/PKA signaling → bronchodilation and cytokine modulation Dual bronchodilatory and immunomodulatory activity (Said)
PACAP (Pituitary Adenylate Cyclase–Activating Peptide) Bronchodilation and systemic vasodilation Shares VPAC receptors; activates adenylate cyclase more strongly than VIP Produces stronger systemic vascular effects (Prieto)
Adrenomedullin Endothelial protection and vascular remodeling Binds CLR/RAMP receptors → NO production and angiogenic signaling Focuses on endothelial repair, not airway tone (Luts et al.)
Substance P Airway inflammation and bronchoconstriction Acts via neurokinin receptors → increases smooth muscle contraction and cytokine release Induces effects opposite to VIP, promoting bronchoconstriction (Joos et al.)

This comparison highlights VIP’s unique ability to combine airway relaxation with immune regulation, setting it apart from related neuropeptides that act primarily on vascular or inflammatory pathways.

Where to Get VIP for Research

Researchers can obtain Vasoactive Intestinal Peptide (VIP) from Tydes, where it is produced under GMP-certified conditions to ensure consistency and reliability. Each batch undergoes independent analytical testing for purity, sequence verification, and peptide stability, and is supplied with a Certificate of Analysis (COA) for full transparency.

All peptides are stored and shipped under controlled temperature conditions to preserve biological activity throughout handling. Tydes also provides research documentation and technical support for studies focusing on respiratory function, vascular regulation, and neuroimmune signaling, helping ensure dependable results in experimental use.

Vasoactive Intestinal Peptide (VIP) represents a central model in respiratory and pulmonary research for its ability to regulate airway relaxation, vascular tone, and immune balance. Through its actions on VPAC1/VPAC2 receptors and downstream signaling pathways, VIP provides insight into how neuropeptides coordinate smooth muscle behavior and inflammation in the respiratory system (Igarashi et al.; Miotto et al.).

As studies continue to explore the roles of neuropeptides in lung health, VIP stands out as a key compound for investigating airway function, pulmonary hypertension, and inflammatory control, advancing our understanding of neuroimmune communication and respiratory regulation (Abad & Tan; Sopi et al.).
0
0
Your Cart
Your cart is emptyReturn to Shop
Continue Shopping